斯洛伐克HIV-1亚型和药物耐药性突变的表征:更新2017-2018年
Bratislavske lekarske listy
|February 22, 2024
概括
斯洛伐克 (2017-2018) 主导的HIV-1 B亚型对传输耐药菌株的风险很小,尽管HIV-1亚型多样性略有增加.
科学领域:
- 病毒学 病毒学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 斯洛伐克的人类免疫缺陷病毒 (HIV) 流行病的发病率很低.
- 观察到HIV菌株异质性的轻微增加.
- 了解流通的艾滋病毒亚型对于公共卫生战略至关重要.
研究的目的:
- 从2017年到2018年在斯洛伐克流行的HIV-1亚型的特征.
- 评估与抗逆转录病毒治疗 (ART) 耐药的HIV菌株传播相关的风险.
主要方法:
- 来自110名新诊断患者的部分HIV多基因序列的分析.
- 基因型分析以确定耐药性突变和确定HIV亚型.
主要成果:
- 艾滋病毒-1亚型B占主导地位 (84.55%),主要与与男性发生性关系 (MSM) 的男性有关.
- 18人 (15.45%) 感染了非B型HIV-1亚型.
- 检测到与抗逆转录病毒治疗 (ART) 耐药性相关的零星突变.
结论:
- 在斯洛伐克,传播耐药性HIV病毒株的风险极小.
- 发现HIV-1亚型的多样性略有增加.
- 在研究期间,HIV-1亚型B仍然是斯洛伐克最常见的亚型.
更多相关视频
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
15.6K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.1K
相关概念视频
Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
